Prevention of neonatal group B streptococcal infection

New England Journal of Medicine

Volumn 347, Issue 4, 2002, Pages 280-281

  Eschenbach, David A ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; DIAGNOSTIC ACCURACY; EDITORIAL; ESCHERICHIA COLI; HUMAN; INFECTION PREVENTION; MEMBRANE RUPTURE; MORTALITY; NEWBORN; NEWBORN INFECTION; PREMATURE LABOR; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; STREPTOCOCCUS AGALACTIAE;

ANTIBIOTIC PROPHYLAXIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; IMMUNIZATION; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; RISK FACTORS; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0037173464     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe020068     Document Type: Editorial

References (15)

1. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis
2. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
3. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: A decision analysis
4. Prevention of perinatal group B streptococcal disease: A public health perspective
5. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates
6. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants
7. Antimicrobial prophylaxis in surgery
8. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types 1a and 1b
9. Maternal immunization to prevent neonatal infections
10. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale
11. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor
12. The fetal inflammatory response syndrome
13. Amniotic fluid infection, cytokines, and adverse outcome among infants at 34 weeks' gestation or less
14. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years